About BioAgilytix
BioAgilytix offers specialized bioanalytical testing services for the pharmaceutical, biotechnology, and agricultural biotechnology industries, focusing on large molecule studies essential for drug development. They provide various assays, including pharmacokinetics, pharmacodynamics, cell-based, and immunogenicity assays, to measure drug effects and safety. With a global presence, particularly in Europe, BioAgilytix distinguishes itself by its comprehensive testing services tailored to the needs of life sciences companies. Their goal is to support the development and validation of new treatments while ensuring the safety and efficacy of agricultural products.
Durham, North CarolinaHeadquarters
2008Year Founded
$29.3MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Health Savings Account/Flexible Spending Account
Unlimited Paid Time Off
Paid Vacation
Paid Sick Leave
Paid Holidays
401(k) Company Match
Parental Leave
Employee Referral Bonus
Risks
Cancellation of Durham expansion may impact growth and local economic contributions.
Regulatory challenges may arise in US market for Stockholm3 prostate cancer test.
Hamburg lab expansion may strain resources, affecting service quality.
Differentiation
Specializes in immunoassays and cell-based assays for large molecule studies.
Operates globally with significant presence in Europe and the US.
Offers comprehensive suite of assays including PK, PD, and immunogenicity.
Upsides
Increased demand for personalized medicine boosts need for specialized testing services.
Growing market for biosimilars and biobetters expands client base opportunities.
Global cell-based assay market growth aligns with BioAgilytix's expertise.
Funding
Total raised$29.27 M
StageGROWTH_EQUITY_VC
GROWTH EQUITY VC
1/31/2019$30